SEARCH

SEARCH BY CITATION

References

  • 1
    Doddoli C,Aragon A,Barlesi F, et al. Does the extent of lymph node dissection influence outcome in patients with stage I non-small cell lung cancer? Eur J Cardiothorac Surg. 2005; 27: 680685.
  • 2
    Keller SM,Adak S,Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIA non-small cell lung cancer. Ann Thorac Surg. 2000; 70: 358366.
  • 3
    Lardinois D,Suter H,Hakki H, et al. Morbidity, survival, and site of recurrence after mediastinal lymph node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2005; 80: 268275.
  • 4
    Rami-Porta R,Wittekind C,Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005; 49: 2533.
  • 5
    Gajra A,Newman N,Gamble G, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small cell lung cancer. J Clin Oncol. 2003; 21: 10291034.
  • 6
    Funatsu T,Matsubara Y,Ikeda S, et al. Pre-operative mediastinoscopic assessment of N factors and the need for mediastinal node dissection in T1 lung cancer. J Thorac Cardiovasc Surg. 1994; 108: 321328.
  • 7
    Nakahara K,Fujii Y,Matsumura A. Role of systemic mediastinal dissection in N2 non-small cell lung cancer patients. Ann Thorac Surg. 1993; 56: 331336.
  • 8
    Ginsberg RJ. Lymph node involvement, recurrence and prognosis in resected small, peripheral, non-small cell lung carcinomas [editorial]. J Thorac Cardiovasc Surg. 1996; 111: 11231124.
  • 9
    Wu Y,Huang Z,Wang S. A randomized trial of systemic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002; 36: 16.
  • 10
    Sugi K,Nawata K,Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg. 1998; 22: 290295.
  • 11
    Izbicki JR,Passlick B,Pantel K, et al. Effectiveness of radical systemic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Ann Surg. 1998; 227: 138144.
  • 12
    Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2003), National Cancer Institute, DCCPS, Surveillance Research Statistics Branch. Available at:http://seer.cancer.gov/publicdata/ Accessed May 3, 2006.
  • 13
    Surveillance, Epidemiology and End Results (SEER) Program. Data quality. Available at: http://seer.cancer.gov/about/quality.html Accessed May 3, 2006.
  • 14
    Leong SS,Rocha Lima CM,Sherman CA,Green MR. The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed? Chest. 1999; 115: 242248.
  • 15
    Kaplan ES,Meier P. Non-parametric estimation from incomplete observation. Am Stat Assoc. 1958; 53: 475480.
  • 16
    Mantel N. Evaluation of survival data and 2 new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50: 163170.
  • 17
    Brock MV,Hooker CM,Ota-Machida E, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008; 358: 11181128.
  • 18
    Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995; 60: 615623.
  • 19
    Czerny M,Fleck T,Salat A, et al. Sealing of the mediastinum with local hemostypic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II NSCLC. Ann Thorac Surg. 2004; 77: 10281032.
  • 20
    Ziomek S,Read RC,Tobler HG, et al. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg. 1993; 56: 223226.
  • 21
    Manser R,Wright G,Hart D, et al. Surgery for early stage non-small cell lung cancer. Cochrane Libr. 2006; 2: 139.
  • 22
    Oda M,Watanabe Y,Shimizu J, et al. Extent of mediastinal node metastasis node metastasis in clinical stage I non-small cell lung cancer: the role of systemic nodal dissection. Lung Cancer. 1998; 22: 2330.
  • 23
    Passlick B,Kubuschock B,Sienel W, et al. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases—results of a preliminary study. Eur J Cardiothorac Surg. 2002; 21: 520526.
  • 24
    Landinois D,Brack T,Gaspert A, et al. Bronchoscopic radio-isotope injection for sentinel lymph-node mapping in potentially resectable non-small cell lung cancer. Eur J Cardiothorac Surg. 2003; 23: 824827.
  • 25
    Wu J,Ohta Y,Minato H, et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg. 2001; 71: 17721778.
  • 26
    Asamura H,Nakayama H,Kondo H, et al. Lobe-specific extent of systemic lymph node dissection for non-small cell carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999; 117: 11021111.
  • 27
    DeGiacomo T,Venuta F,Rendina EA. Role of lymphadenectomy in the treatment of clinical stage I non-small cell lung cancer. Thorac Surg Clin. 2007; 17: 217221.